Hebert, A., Schrieber, R., Glaab, D. and Eichenfield, L. (2020) “Phase IV Open Label Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of Twice Daily Halobetasol propionate Foam, 0.05% in Adolescent Subjects with Plaque Psoriasis”, SKIN The Journal of Cutaneous Medicine, 4(6), p. s77. doi: 10.25251/skin.4.supp.77.